VENA CAVA FILTERS TO SEE DOUBLE-DIGIT CAGR ANNUAL GROWTH
The global inferior vena cava filters (IVCFs)market is expected to grow at a compounded annual growth rate (CAGR) of more than 11 percent during the period 2018-2022, according to a new 126-page market research study (SKU: IRTNTR21662) published early this year by Technavio. A free sample report or the full
INTACT VASCULAR OFFERS TOBA BTK DATA
Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, has praised the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue of Catheterization and Cardiovascular Intervention. This multi-center pilot study focused on collecting data supporting
AMERICAN VEIN AIDS HEALTH4HAITI BY DONATING 50 SETS OF SCRUBS
American Vein & Vascular Institute recently donated more than 50 sets of scrubs to Health4Haiti, a non-profit that improves lives and healthcare outcomes for the citizens of Gonaives, Haiti. Gonaives is currently served by one public hospital, according to Health4Haiti’s website (healthfourhaiti.com), and that hospital has been destroyed twice due
MOST VENOUS DISEASE CAN BE CLASSIFIED AS COSMETIC
By Ronald Bush, MD, FACS In 1992, I left a busy practice of thoracic and vascular surgery and began the in-office treatment of varicose veins. At that time, high ligation and stripping using tumescent with ultra sound guided assistance was our treatment of choice for saphenous insufficiency.
CASE STUDY: MANAGING PERSISTENT SWELLING AFTER ENDOVENOUS ABLATION
By Tim Crawlield I have practiced phleboloby for six years and I learned early in my career that patients with swelling in the lower extremities — swelling that cannot be contained by elastic graduated compression stockings — do not benefit from endovenous ablations. My general rule of thumb is
2018 RESEARCH SUMMIT: WORK BEGINS TO ANALYZE DATA IN RAPIDLY EXPANDING ACP PRO VENOUS REGISTRY
By Vanessa Salvia Contributing Editor Anticipation was high for many members of the phlebology community going into an April 21 closed-door research summit held alongside the International Vein Congress in Miami, convened to discuss how to make the most of the American College of Phlebology’s Patient Recorded Outcome Venous Registry,
OPTALYSE PE: BTG RESULTS REINFORCE SAFETY, EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE
BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to
![](https://www.veintherapynews.com/wp-content/uploads/2017/11/Vein-bar-blue_featured_image-360x90.jpg)
INTACT VASCULAR SPONSORS SYMPOSIUM ON POST-ANGIOPLASTY DISSECTIONS MAY 31
Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced May 29 the schedule of key presentations that will be featured during a symposium sponsored together with Philips at the 19th Annual New Cardiovascular Horizons (NCVH) Conference in New Orleans on May 31. Post-Percutaneous Transluminal Angioplasty (“PTA”)
THANK YOU! THE HEROISM OF NURSES IN OUR PRACTICES AND IN OUR LIVES SHOULD BE A DAILY CELEBRATION
National Nurses Day was May 6 and National Nurses Week ends May 12, which is Florence Nightingale’s birthday. Nurse Nightingale, who came to prominence while serving as a British manager and trainer of nurses during the Crimean War, is the founder of modern nursing and it’s appropriate that on
JOHN CHUBACK, MD, FACS, JOINS VEIN THERAPY NEWS EDITORIAL ADVISORY BOARD
John Chuback, MD, FACS, chief medical officer at Chuback Medical Group in Paramus, N.J., has joined the Vein Therapy News (VTN) Editorial Advisory Board. Dr. Chuback is involved in teaching, entrepreneurship, writing and philanthropy. He is also co-founder of BiosupportMD and Chuback Education. He is an author of numerous articles